Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based healthcare company Abbott Laboratories has announced sales of $7.49 billion for the third quarter of 2008, an increase of 17.6%, compared to $6.37 billion posted in the third quarter of 2007.
Subscribe to our email newsletter
Net earnings for the third quarter of 2008 were $1.08 billion, an increase of 51.3%, compared to $717 million posted in the third quarter of 2007. Diluted earnings per share for the third quarter of 2008 were $0.69, an increase of 50%, compared to $0.46 posted in the third quarter of 2007.
The company reported sales of $21.5 billion for the first nine months of 2008, an increase of 15.4%, compared to $18.6 billion posted in the same period of 2007.
Net earnings for the first nine months of 2008 were $3.3 billion, an increase of 39.2%, compared to $2.4 billion posted in the same period of 2007. Net diluted earnings per share for the first nine months of 2008 were $2.14, an increase of 39%, compared to $1.54 posted in the same period of 2007.
Miles White, chairman and CEO of Abbott, said: “All of Abbott’s businesses are performing exceptionally well, ahead of expectations. Abbott remains well-positioned, with strong core growth franchises, including our emerging vascular business, which is rapidly becoming a significant contributor to Abbott’s growth.”